1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Alnylam Pharmaceuticals

Anonymous board for Alnylam


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    4
    Views:
    1,475
  2. anonymous
    Replies:
    6
    Views:
    1,255
  3. anonymous
    Replies:
    10
    Views:
    2,901
  4. anonymous
    Replies:
    5
    Views:
    1,076
  5. anonymous
    Replies:
    2
    Views:
    1,118
  6. anonymous
    Replies:
    9
    Views:
    1,127
  7. anonymous
    Replies:
    2
    Views:
    957
  8. anonymous
    Replies:
    12
    Views:
    2,206
  9. anonymous
    Replies:
    9
    Views:
    2,962
  10. anonymous
    Replies:
    11
    Views:
    6,726
  11. anonymous
    Replies:
    38
    Views:
    6,121
  12. anonymous
    Replies:
    4
    Views:
    1,547
  13. anonymous
    Replies:
    14
    Views:
    1,933
  14. anonymous
    Replies:
    4
    Views:
    1,284
  15. anonymous
    Replies:
    2
    Views:
    1,008
  16. anonymous
    Replies:
    3
    Views:
    866
  17. anonymous
    Replies:
    7
    Views:
    1,017
  18. anonymous
    Replies:
    1
    Views:
    718
  19. anonymous
    Replies:
    2
    Views:
    820
  20. anonymous
    Replies:
    14
    Views:
    1,367

Thread Display Options

Loading...